Vertos Medical

Executive Summary

Vertos Medical, now operating as Stryker's Interventional Spine division, is a medical device company focused on minimally invasive treatments for chronic back pain and spinal conditions. Its flagship mild® procedure treats lumbar spinal stenosis by removing excess ligament tissue, and its portfolio includes vertebral augmentation systems, bone tumor ablation, and the OptaBlate® basivertebral nerve ablation system. Following its acquisition by Stryker, Vertos benefits from Stryker's global commercial infrastructure and R&D capabilities, positioning it to expand adoption of its differentiated, minimally invasive spine technologies. The company's solutions address a large and growing patient population seeking alternatives to open surgery, with the mild procedure and OptaBlate offering strong clinical evidence and reimbursement coverage.

Upcoming Catalysts (preview)

• Q4 2026Expansion of mild procedure indications to include multi-level lumbar spinal stenosis75% success
• Q2 2026Publication of pivotal study data for OptaBlate® in chronic low back pain80% success
• Q1 2027Integration of Vertos technology into Stryker's Mako robotic platform for spine surgery60% success